Cargando…
Synthesis, in vitro inhibitory activity, kinetic study and molecular docking of novel N-alkyl–deoxynojirimycin derivatives as potential α-glucosidase inhibitors
A series of novel N-alkyl-1-deoxynojirimycin derivatives 25 ∼ 44 were synthesised and evaluated for their in vitro α-glucosidase inhibitory activity to develop α-glucosidase inhibitors with high activity. All twenty compounds exhibited α-glucosidase inhibitory activity with IC(50) values ranging fro...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7580737/ https://www.ncbi.nlm.nih.gov/pubmed/33003963 http://dx.doi.org/10.1080/14756366.2020.1826941 |
_version_ | 1783598836873166848 |
---|---|
author | Lin, Ping Zeng, Jia-Cheng Chen, Ji-Guang Nie, Xu-Liang Yuan, En Wang, Xiao-Qiang Peng, Da-Yong Yin, Zhong-Ping |
author_facet | Lin, Ping Zeng, Jia-Cheng Chen, Ji-Guang Nie, Xu-Liang Yuan, En Wang, Xiao-Qiang Peng, Da-Yong Yin, Zhong-Ping |
author_sort | Lin, Ping |
collection | PubMed |
description | A series of novel N-alkyl-1-deoxynojirimycin derivatives 25 ∼ 44 were synthesised and evaluated for their in vitro α-glucosidase inhibitory activity to develop α-glucosidase inhibitors with high activity. All twenty compounds exhibited α-glucosidase inhibitory activity with IC(50) values ranging from 30.0 ± 0.6 µM to 2000 µM as compared to standard acarbose (IC(50) = 822.0 ± 1.5 µM). The most active compound 43 was ∼27-fold more active than acarbose. Kinetic study revealed that compounds 43, 40, and 34 were all competitive inhibitors on α-glucosidase with K(i)of 10 µM, 52 µM, and 150 µM, respectively. Molecular docking demonstrated that the high active inhibitors interacted with α-glucosidase by four types of interactions, including hydrogen bonds, π–π stacking interactions, hydrophobic interactions, and electrostatic interaction. Among all the interactions, the π–π stacking interaction and hydrogen bond played a significant role in a various range of activities of the compounds. |
format | Online Article Text |
id | pubmed-7580737 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-75807372020-10-29 Synthesis, in vitro inhibitory activity, kinetic study and molecular docking of novel N-alkyl–deoxynojirimycin derivatives as potential α-glucosidase inhibitors Lin, Ping Zeng, Jia-Cheng Chen, Ji-Guang Nie, Xu-Liang Yuan, En Wang, Xiao-Qiang Peng, Da-Yong Yin, Zhong-Ping J Enzyme Inhib Med Chem Research Paper A series of novel N-alkyl-1-deoxynojirimycin derivatives 25 ∼ 44 were synthesised and evaluated for their in vitro α-glucosidase inhibitory activity to develop α-glucosidase inhibitors with high activity. All twenty compounds exhibited α-glucosidase inhibitory activity with IC(50) values ranging from 30.0 ± 0.6 µM to 2000 µM as compared to standard acarbose (IC(50) = 822.0 ± 1.5 µM). The most active compound 43 was ∼27-fold more active than acarbose. Kinetic study revealed that compounds 43, 40, and 34 were all competitive inhibitors on α-glucosidase with K(i)of 10 µM, 52 µM, and 150 µM, respectively. Molecular docking demonstrated that the high active inhibitors interacted with α-glucosidase by four types of interactions, including hydrogen bonds, π–π stacking interactions, hydrophobic interactions, and electrostatic interaction. Among all the interactions, the π–π stacking interaction and hydrogen bond played a significant role in a various range of activities of the compounds. Taylor & Francis 2020-10-01 /pmc/articles/PMC7580737/ /pubmed/33003963 http://dx.doi.org/10.1080/14756366.2020.1826941 Text en © 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Paper Lin, Ping Zeng, Jia-Cheng Chen, Ji-Guang Nie, Xu-Liang Yuan, En Wang, Xiao-Qiang Peng, Da-Yong Yin, Zhong-Ping Synthesis, in vitro inhibitory activity, kinetic study and molecular docking of novel N-alkyl–deoxynojirimycin derivatives as potential α-glucosidase inhibitors |
title | Synthesis, in vitro inhibitory activity, kinetic study and molecular docking of novel N-alkyl–deoxynojirimycin derivatives as potential α-glucosidase inhibitors |
title_full | Synthesis, in vitro inhibitory activity, kinetic study and molecular docking of novel N-alkyl–deoxynojirimycin derivatives as potential α-glucosidase inhibitors |
title_fullStr | Synthesis, in vitro inhibitory activity, kinetic study and molecular docking of novel N-alkyl–deoxynojirimycin derivatives as potential α-glucosidase inhibitors |
title_full_unstemmed | Synthesis, in vitro inhibitory activity, kinetic study and molecular docking of novel N-alkyl–deoxynojirimycin derivatives as potential α-glucosidase inhibitors |
title_short | Synthesis, in vitro inhibitory activity, kinetic study and molecular docking of novel N-alkyl–deoxynojirimycin derivatives as potential α-glucosidase inhibitors |
title_sort | synthesis, in vitro inhibitory activity, kinetic study and molecular docking of novel n-alkyl–deoxynojirimycin derivatives as potential α-glucosidase inhibitors |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7580737/ https://www.ncbi.nlm.nih.gov/pubmed/33003963 http://dx.doi.org/10.1080/14756366.2020.1826941 |
work_keys_str_mv | AT linping synthesisinvitroinhibitoryactivitykineticstudyandmoleculardockingofnovelnalkyldeoxynojirimycinderivativesaspotentialaglucosidaseinhibitors AT zengjiacheng synthesisinvitroinhibitoryactivitykineticstudyandmoleculardockingofnovelnalkyldeoxynojirimycinderivativesaspotentialaglucosidaseinhibitors AT chenjiguang synthesisinvitroinhibitoryactivitykineticstudyandmoleculardockingofnovelnalkyldeoxynojirimycinderivativesaspotentialaglucosidaseinhibitors AT niexuliang synthesisinvitroinhibitoryactivitykineticstudyandmoleculardockingofnovelnalkyldeoxynojirimycinderivativesaspotentialaglucosidaseinhibitors AT yuanen synthesisinvitroinhibitoryactivitykineticstudyandmoleculardockingofnovelnalkyldeoxynojirimycinderivativesaspotentialaglucosidaseinhibitors AT wangxiaoqiang synthesisinvitroinhibitoryactivitykineticstudyandmoleculardockingofnovelnalkyldeoxynojirimycinderivativesaspotentialaglucosidaseinhibitors AT pengdayong synthesisinvitroinhibitoryactivitykineticstudyandmoleculardockingofnovelnalkyldeoxynojirimycinderivativesaspotentialaglucosidaseinhibitors AT yinzhongping synthesisinvitroinhibitoryactivitykineticstudyandmoleculardockingofnovelnalkyldeoxynojirimycinderivativesaspotentialaglucosidaseinhibitors |